Tilray Brands (TLRY) Net Income towards Common Stockholders (QoQ) (2017 - 2026)
Tilray Brands (TLRY) Net Income towards Common Stockholders (QoQ) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.15 Bn | 39.49 Bn | 2.15 Bn |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.58 Bn | 22.78 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.50 Bn | 683.80 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.48 Bn | 15.09 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - |
| 10 | Tilray Brands | 516.11 Mn | 281.48 Mn | 90.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | -17.45% |
| Feb 28, 2026 | 42.01% |
| Nov 30, 2025 | -2,975.68% |
| Aug 31, 2025 | 100.17% |
| May 31, 2025 | -14.07% |
| Feb 28, 2025 | -830.56% |
| Nov 30, 2024 | -146.09% |
| Aug 31, 2024 | -471.24% |
| May 31, 2024 | 108.89% |
| Feb 29, 2024 | -127.32% |
| Nov 30, 2023 | 17.33% |
| Aug 31, 2023 | -131.47% |
| May 31, 2023 | 114.85% |
| Feb 28, 2023 | -1,305.76% |
| Nov 30, 2022 | -29.28% |
| Aug 31, 2022 | 82.30% |
| May 31, 2022 | -808.53% |
| Feb 28, 2022 | 805.21% |
| Nov 30, 2021 | 116.75% |
| Aug 31, 2021 | -112.87% |